E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/5/2019 in the Prospect News Bank Loan Daily, Prospect News Investment Grade Daily and Prospect News Liability Management Daily.

Pfizer to refinance, redeem or buy back debt via $5 billion issue

By Susanna Moon

Chicago, March 5 – Pfizer Inc. plans to refinance, redeem or repurchase its debt and to repay a portion of commercial paper using proceeds of new notes.

As reported, Pfizer priced $5 billion of notes in five tranches on Monday with settlement set for March 11.

The biopharmaceutical company is based in New York.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.